nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—DDC—nerve—amyotrophic lateral sclerosis	0.0484	0.108	CbGeAlD
Droxidopa—DDC—hindbrain—amyotrophic lateral sclerosis	0.0363	0.0808	CbGeAlD
Droxidopa—SLC6A2—nerve—amyotrophic lateral sclerosis	0.0231	0.0514	CbGeAlD
Droxidopa—DDC—embryo—amyotrophic lateral sclerosis	0.0227	0.0505	CbGeAlD
Droxidopa—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.0209	0.0466	CbGeAlD
Droxidopa—DDC—brainstem—amyotrophic lateral sclerosis	0.0208	0.0463	CbGeAlD
Droxidopa—PAH—nervous system—amyotrophic lateral sclerosis	0.0191	0.0425	CbGeAlD
Droxidopa—PAH—central nervous system—amyotrophic lateral sclerosis	0.0184	0.041	CbGeAlD
Droxidopa—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.0161	0.0358	CbGeAlD
Droxidopa—PAH—brain—amyotrophic lateral sclerosis	0.0146	0.0325	CbGeAlD
Droxidopa—DDC—nervous system—amyotrophic lateral sclerosis	0.0109	0.0243	CbGeAlD
Droxidopa—DDC—central nervous system—amyotrophic lateral sclerosis	0.0105	0.0234	CbGeAlD
Droxidopa—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00991	0.0221	CbGeAlD
Droxidopa—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00921	0.0205	CbGeAlD
Droxidopa—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00859	0.0191	CbGeAlD
Droxidopa—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.0084	0.0187	CbGeAlD
Droxidopa—DDC—brain—amyotrophic lateral sclerosis	0.00833	0.0185	CbGeAlD
Droxidopa—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00827	0.0184	CbGeAlD
Droxidopa—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.00809	0.018	CbGeAlD
Droxidopa—SLC16A10—cerebellum—amyotrophic lateral sclerosis	0.00703	0.0157	CbGeAlD
Droxidopa—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.00691	0.0154	CbGeAlD
Droxidopa—ADRA1B—brain—amyotrophic lateral sclerosis	0.00656	0.0146	CbGeAlD
Droxidopa—ADRA1D—brain—amyotrophic lateral sclerosis	0.00642	0.0143	CbGeAlD
Droxidopa—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00612	0.0136	CbGeAlD
Droxidopa—ADRB1—nervous system—amyotrophic lateral sclerosis	0.0061	0.0136	CbGeAlD
Droxidopa—ADRB1—central nervous system—amyotrophic lateral sclerosis	0.00588	0.0131	CbGeAlD
Droxidopa—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00546	0.0121	CbGeAlD
Droxidopa—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.00519	0.0116	CbGeAlD
Droxidopa—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.005	0.0111	CbGeAlD
Droxidopa—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00488	0.0109	CbGeAlD
Droxidopa—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00483	0.0107	CbGeAlD
Droxidopa—ADRB1—brain—amyotrophic lateral sclerosis	0.00466	0.0104	CbGeAlD
Droxidopa—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00465	0.0103	CbGeAlD
Droxidopa—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.0046	0.0102	CbGeAlD
Droxidopa—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00454	0.0101	CbGeAlD
Droxidopa—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.00443	0.00986	CbGeAlD
Droxidopa—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00435	0.00969	CbGeAlD
Droxidopa—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.00433	0.00963	CbGeAlD
Droxidopa—SLC6A2—brain—amyotrophic lateral sclerosis	0.00397	0.00883	CbGeAlD
Droxidopa—ADRA1A—brain—amyotrophic lateral sclerosis	0.00369	0.00821	CbGeAlD
Droxidopa—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00367	0.00817	CbGeAlD
Droxidopa—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.00353	0.00786	CbGeAlD
Droxidopa—ADRA2C—brain—amyotrophic lateral sclerosis	0.00351	0.00782	CbGeAlD
Droxidopa—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00345	0.00769	CbGeAlD
Droxidopa—ADRA2A—brain—amyotrophic lateral sclerosis	0.0028	0.00624	CbGeAlD
Droxidopa—Aminosalicylic Acid—PTGS2—amyotrophic lateral sclerosis	0.00192	0.56	CrCbGaD
Droxidopa—Mesalazine—PTGS2—amyotrophic lateral sclerosis	0.00151	0.44	CrCbGaD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000489	0.000896	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000484	0.000887	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000482	0.000884	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000481	0.000882	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000476	0.000873	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000475	0.00087	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000473	0.000867	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000471	0.000863	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000469	0.000859	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000463	0.000848	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.00045	0.000824	CbGpPWpGaD
Droxidopa—PAH—Metabolism—APOE—amyotrophic lateral sclerosis	0.000447	0.00082	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000442	0.000809	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000438	0.000802	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—DAO—amyotrophic lateral sclerosis	0.000438	0.000802	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000431	0.00079	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000428	0.000784	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000422	0.000773	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.00042	0.00077	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000408	0.000748	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000405	0.000742	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000404	0.00074	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000404	0.000739	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000402	0.000737	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000399	0.000731	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000397	0.000728	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000394	0.000721	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000394	0.000721	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000392	0.000718	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000383	0.000702	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000383	0.000702	CbGpPWpGaD
Droxidopa—DDC—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000383	0.000701	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000381	0.000697	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000377	0.000691	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GSR—amyotrophic lateral sclerosis	0.000377	0.00069	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000373	0.000683	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000369	0.000676	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000367	0.000672	CbGpPWpGaD
Droxidopa—PAH—Disease—PTGS2—amyotrophic lateral sclerosis	0.000366	0.000671	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000365	0.00067	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000361	0.000661	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000361	0.000661	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000356	0.000652	CbGpPWpGaD
Droxidopa—DDC—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000352	0.000645	CbGpPWpGaD
Droxidopa—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.000352	0.212	CcSEcCtD
Droxidopa—ADRA1D—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000349	0.00064	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000348	0.000638	CbGpPWpGaD
Droxidopa—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000348	0.000637	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000347	0.000635	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000344	0.00063	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000341	0.000626	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000341	0.000625	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000339	0.000622	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000336	0.000616	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000332	0.000608	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000329	0.000602	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000326	0.000597	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000326	0.000597	CbGpPWpGaD
Droxidopa—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000325	0.000595	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000324	0.000593	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000322	0.000589	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000321	0.000588	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000318	0.000583	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000316	0.000579	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000315	0.000578	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000311	0.000571	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00031	0.000568	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000309	0.000567	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000307	0.000562	CbGpPWpGaD
Droxidopa—PAH—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000307	0.000562	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000306	0.000561	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GSR—amyotrophic lateral sclerosis	0.000306	0.000561	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000304	0.000558	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000303	0.000556	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000303	0.000554	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000299	0.000549	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000298	0.000547	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000295	0.00054	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00029	0.000531	CbGpPWpGaD
Droxidopa—DDC—Metabolism—APOE—amyotrophic lateral sclerosis	0.000289	0.00053	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000289	0.00053	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000283	0.000518	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000281	0.000514	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00028	0.000513	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00028	0.000512	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000277	0.000508	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000277	0.000507	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000277	0.000507	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000274	0.000503	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000273	0.000501	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000266	0.000487	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000264	0.000483	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000262	0.000479	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000261	0.000478	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000259	0.000474	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000258	0.000472	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000258	0.000472	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000257	0.00047	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000256	0.00047	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000255	0.000467	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000251	0.00046	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.00025	0.000457	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000247	0.000453	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000247	0.000453	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000239	0.000439	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000234	0.000428	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000233	0.000426	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000232	0.000424	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000229	0.000419	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000229	0.000419	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000227	0.000417	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000227	0.000415	CbGpPWpGaD
Droxidopa—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.000226	0.136	CcSEcCtD
Droxidopa—ADRA1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000226	0.000414	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000225	0.000413	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000222	0.000408	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000216	0.000396	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000213	0.00039	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000213	0.000389	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000211	0.000386	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000211	0.000386	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00021	0.000385	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000208	0.000381	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000207	0.00038	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000207	0.000378	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000206	0.000377	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000205	0.000375	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000202	0.00037	CbGpPWpGaD
Droxidopa—DDC—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000198	0.000363	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000198	0.000362	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000192	0.000352	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000191	0.000351	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000191	0.00035	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00019	0.000349	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000189	0.000346	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000188	0.000345	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000188	0.000345	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000188	0.000344	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000184	0.000337	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00018	0.00033	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000179	0.000328	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000178	0.000327	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000178	0.000326	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000176	0.000323	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000176	0.000322	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000175	0.000321	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000172	0.000314	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000171	0.000313	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00017	0.000311	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000168	0.000307	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000167	0.000307	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000167	0.000306	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000167	0.000305	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000166	0.000305	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000164	0.000301	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000161	0.000295	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000159	0.000291	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000158	0.00029	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000156	0.000286	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000155	0.000285	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000155	0.000285	CbGpPWpGaD
Droxidopa—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000154	0.0927	CcSEcCtD
Droxidopa—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000153	0.00028	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000152	0.000278	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000147	0.000269	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000146	0.000267	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000146	0.000267	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000144	0.000265	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000144	0.000263	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000139	0.000254	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000138	0.000253	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000137	0.000251	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000136	0.000249	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000136	0.000249	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000135	0.000248	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000135	0.000248	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000135	0.000247	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000135	0.000247	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000134	0.000245	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000134	0.000245	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000129	0.000236	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000128	0.000234	CbGpPWpGaD
Droxidopa—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000127	0.0765	CcSEcCtD
Droxidopa—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000126	0.000232	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000126	0.00023	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	0.000126	0.00023	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000125	0.000228	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000124	0.000227	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000122	0.000224	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000122	0.000223	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000121	0.000222	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000119	0.000219	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000119	0.000218	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000115	0.000211	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000114	0.000208	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000113	0.000207	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000113	0.000206	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000112	0.000205	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000111	0.000204	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000111	0.000204	CbGpPWpGaD
Droxidopa—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000111	0.0668	CcSEcCtD
Droxidopa—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.00011	0.000202	CbGpPWpGaD
Droxidopa—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000109	0.0655	CcSEcCtD
Droxidopa—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000107	0.0643	CcSEcCtD
Droxidopa—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000105	0.000193	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000104	0.00019	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000103	0.00019	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000103	0.000189	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000103	0.000189	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000103	0.000188	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	0.000102	0.000187	CbGpPWpGaD
Droxidopa—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000102	0.0613	CcSEcCtD
Droxidopa—Shock—Riluzole—amyotrophic lateral sclerosis	9.92e-05	0.0598	CcSEcCtD
Droxidopa—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.87e-05	0.000181	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.39e-05	0.000172	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.3e-05	0.00017	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.19e-05	0.000168	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.18e-05	0.000168	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.17e-05	0.000168	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.69e-05	0.000159	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.62e-05	0.000158	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.55e-05	0.000157	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.54e-05	0.000156	CbGpPWpGaD
Droxidopa—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	8.31e-05	0.0501	CcSEcCtD
Droxidopa—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.93e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.8e-05	0.000143	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.59e-05	0.000139	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.49e-05	0.000137	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.23e-05	0.000132	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.16e-05	0.000131	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.07e-05	0.000129	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.06e-05	0.000129	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	7e-05	0.000128	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.83e-05	0.000125	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.77e-05	0.000124	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.73e-05	0.000123	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.69e-05	0.000123	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.68e-05	0.000122	CbGpPWpGaD
Droxidopa—Dizziness—Riluzole—amyotrophic lateral sclerosis	6.67e-05	0.0402	CcSEcCtD
Droxidopa—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.58e-05	0.000121	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.32e-05	0.000116	CbGpPWpGaD
Droxidopa—Headache—Riluzole—amyotrophic lateral sclerosis	6.32e-05	0.0381	CcSEcCtD
Droxidopa—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.22e-05	0.000114	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.13e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.07e-05	0.000111	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6e-05	0.00011	CbGpPWpGaD
Droxidopa—Nausea—Riluzole—amyotrophic lateral sclerosis	5.99e-05	0.0361	CcSEcCtD
Droxidopa—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.85e-05	0.000107	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.67e-05	0.000104	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.58e-05	0.000102	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.52e-05	0.000101	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.43e-05	9.95e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.13e-05	9.4e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.08e-05	9.32e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.96e-05	9.09e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.63e-05	8.49e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.61e-05	8.44e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.59e-05	8.41e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.53e-05	8.3e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.29e-05	7.86e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.22e-05	7.73e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.75e-05	6.87e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.48e-05	6.38e-05	CbGpPWpGaD
